Stockreport

Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com
PDF - MOMENTUM trial designed to confirm the unique benefits of momelotinib on all three hallmarks of myelofibrosis: symptoms, anemia and enlarged spleen -- Targeting enroll [Read more]